Cu-C-DOTA and 64 Cu-3p-C-DE4TA. 64 Cu complexes of the new chelates 3p-C-NE3TA and 3p-C-NOTA displayed comparable in vitro and in vivo complex stability to 
Introduction
Positron emission tomography (PET) is a nuclear imaging technique that has been used for diagnostics and staging of various cancers [1] [2] [3] . Highly energetic photons released from positron-electron annihilation process make acquisition of PET images in high-resolution feasible using a molecular probe in a picomolar range [3] . Fluorine-18 (t 1/2 = 110 min) has been extensively explored as a positron probe for PET imaging, and 18 F-fluoro-2-deoxy-glucose ( 18 F-FDG) is the most frequently used drug for PET imaging of cancer [1] [2] [3] . However, the short half-life of 18 F and synthetic challenges in preparation of the 18 F-radiolabeled molecular tracers remain limitations for broad applications of 18 F-PET imaging. Among metallic radionuclides for PET imaging, copper-64 (t 1/2 = 12.7 h; E β+ max = 0.655 MeV; E β− max = 0.573 MeV; E γ max = 0.511 MeV) is of great interest due to its favorable physical properties [4] [5] [6] . 64 Cu can be readily produced in large quantities using a cyclotron and has longer half-life (t 1/2 = 12.7 h) than fluorine-18, and its β − emission can be utilized for radiotherapy. The coordination chemistry of copper has been well studied and applied for the design of adequate chelates for efficient radiolabeling with 64 Cu [7] [8] [9] [10] . Macrocyclic chelates including DOTA (1,4,7,10-tetraazacyclododecane-N,N′,N″,N″′-tetraacetic acid), TETA (1,4,8,11- 64 Cu-based PET imaging [7] [8] [9] . However, the currently available chelates of 64 Cu present limitations for practical use in PET imaging applications including preparation of 64 Cu-radiolabeled chelates under harsh radiolabeling conditions and premature dissociation of 64 Cu from the complexes in vivo [7, [9] [10] [11] [12] [13] . NOTA (1,4,7-triazacyclononane-1,4,7-triacetic acid) is a TACN (1,4,7-Triazacyclononane)-based hexadentate chelate that is known to form a stable complex with 64 Cu in vitro and in vivo [14] . We previously reported NE3TA (7-[2-[carboxymethyl)amino]ethyl]-1,4,7-triazacyclononane-1,4-diacetic acid)-based heptadentate chelates containing both the macrocyclic TACN backbone and a pendant arm. The acyclic-binding moiety appended to the TACN backbone was proposed to enhance complexation kinetics of the chelates by rapidly binding 64 Cu, which can be subsequently solvated by the donors in the TACN backbone to form a stable complex. The bifunctional NE3TA analogs rapidly formed a stable complex with 64 Cu [15] [16] [17] . The bifunctional chelates C-NE3TA (7-[2-[carboxymethyl) amino]-3-(4-nitrophenyl)propyl]-1,4,7-triazacyclononane-1,4-diacetic acid) and N-NE3TA (7-[2-[(carboxymethyl) amino]-2-(4-nitrophenyl)methyl]-1,4,7-triazacyclononane-1,4-diacetic acid) were shown to have superior in vivo stability than 64 Cu-C-DOTA complex [15] . Both C-NE3TA and N-NE3TA conjugated to a tumor targeting biomolecule (transferrin) rapidly bound to 64 Cu at room temperature [18] . N-NE3TA-transferrin conjugate was slightly more efficient in binding 64 Cu than C-NE3TA-transferrin conjugate. 64 Cu-radiolabeled N-NE3TA-transferrin conjugate remained in human serum for 48 h and displayed rapid blood clearance and increasing tumor uptake in PC-3 tumor bearing mice over a 24 h period [18] .
In this study, the potential bifunctional chelates 3p-C-NOTA, 3p-C-NE3TA, and 3p-C-DE4TA (Fig. 1 ) along with the standard chelates C-NOTA and C-DOTA were comparatively evaluated for radiolabeling kinetics and in vitro and in vivo complex stability with 64 Cu. TACNbased chelates 3p-C-NOTA and 3p-C-NE3TA contain six and seven coordinating groups, respectively. 3p-C-DE4TA with nine donors is constructed on relatively larger macrocyclic cyclen (1,4,7,10-tetraazacyclododecane) backbone. All of the chelates studied contain a longer propyl chain which connects the chelating backbone to the functional group (para-nitro-phenyl) for conjugation to a biomolecule. In contrast, C-NOTA and C-DOTA (2-(4-nitrobenzyl)-1,4,7,10-tetraazacyclotetradecane-1,4,7,10-tetraacetic acid) contain a methyl spacer. The relatively long alkyl spacer of the present chelates was proposed to reduce steric hindrance in metal complexation of the chelate conjugated to a protein. The bifunctional chelates were evaluated for radiolabeling kinetics with 64 Cu, and in vitro stability of 64 Curadiolabeled complexes was evaluated in human serum and excess EDTA solution. In vivo stability of 64 Cu-radiolabeled complexes was also assessed by conducting a biodistribution study in mice.
Experimental

Instruments and materials
Analytical HPLC was performed on an Agilent 1200 equipped with a diode array detector (λ = 254 and 280 nm), thermostat set at 35 °C, and a Zorbax Eclipse XDB-C18 column (4.6 × 150 mm, 80 Å). Ultrapure ammonium acetate was purchased from Aldrich. Ultrapure HCl was purchased from Fisher Scientific. Radio-TLC was performed on a TLC scanner (Bioscan, B-FC-1000). 64 Cu in the chloride form (specific activity of 248 mCi/µg) was obtained from Washington University (Saint. Louis, MO).
Complexation formation kinetics of chelates with 64 Cu
Bifunctional chelates 3p-C-NOTA, 3p-C-NE3TA, 3p-C-DE4TA were prepared as previously reported [19] . C-DOTA was purchased from Macrocyclics (Dallas, TX). C-NOTA in the form of NH 2 was prepared by the method reported in the literature [20] . All HCl solutions were prepared from ultrapure HCl (Fisher Scientific). In vitro serum stability of 64 Cu-radiolabeled complexes
Human serum was purchased from Gemini Bioproducts (#100110). 64 Cu-radiolabeled complexes were prepared by reaction of the chelators (30 μg) with 64 Cu (90 μCi) in 0.25 M NH 4 OAc buffer (pH 5.5) for 1 h at room temperature or 90 °C (for C-DOTA). The total volume of the final solution was 10 µL. The labeling efficiency of the radiolabeled complexes was found to be ~100 % as determined by TLC. The freshly prepared radiolabeled complexes were directly used for serum stability studies without further purification. 64 Cu-radiolabeled complex (~75 μCi, ~10 μL) was added to human serum (90 μL) in a microcentrifuge tube. 64 Cu-3p-C-DE4TA were prepared by reaction of the chelators (10 μg) with 64 Cu (30 μCi) in 0.25 M NH 4 OAc buffer (pH 5.5) for 1 h at room temperature. The total volume of the final solution was 20 µL. The labeling efficiency of the radiolabeled complexes was found to be ~100 % as determined by TLC. 64 Cu-radiolabeled complex (~7 μCi, ~20 μL) was added to human serum (60 μL) in a microcentrifuge tube. The stability of 64 Cu-radiolabeled complexes in human serum was evaluated at 37 °C for 2 days using TLC and HPLC (solvent A: 0.1 % TFA in H 2 O, solvent B: 0.1 % TFA in CH 3 CN, 0-100 % B/15 min, flow rate: 1 mL/min). 64 Cu-EDTA complex was eluted early (t R = ~2.5 min), while 64 Cu-radiolabeled complexes of the chelators have longer retention time (4-8 min). 64 Cu-radiolabeled complexes were prepared by reaction of each chelator (10 μg) with 64 Cu (30 μCi) in 0.25 M NH 4 OAc buffer (pH 5.5) for 1 h at room temperature. The total volume of the resulting solution was 20 μL. The freshly prepared radiolabeled complexes were directly used for EDTA challenge experiment without further purification. A solution of the 64 Cu-radiolabeled complex containing each chelator (1 mM) in 0.25 M NH 4 OAc buffer was mixed with a solution of EDTA (100 mM, H 2 O, pH 5.0) at a 100-fold molar excess. The resulting mixture was incubated for 24 h at 37 °C. The stability of 64 Cu-radiolabeled complexes in the solution was evaluated using TLC (20 mM EDTA in 0.15 M NH 4 OAc). Bound and unbound radioisotope appeared 30-40 mm (R f = 0.54) and 48-55 mm (R f = 0.94) from the bottom of the TLC plate, respectively. Stability of the complexes was also evaluated at 24 h time point by HPLC (solvent A: 0.1 % TFA in H 2 O, solvent B: 0.1 % TFA in CH 3 CN, 0-100 % B/15 min, flow rate: 1 mL/min). 64 Cu-EDTA complex was eluted early (t R = ~2.5 min). 64 Cu-radiolabeled complex of 3p-C-NE3TA, 3p-C-NOTA, 3p-C-DE4TA, C-NOTA (in the NH 2 form), and C-DOTA has the respective retention time (t R = 8.2, 8.0, 7.8, 4.2, 7.5 min).
EDTA challenge
Biodistribution
All animal experiments were conducted in accordance with the guidelines established by the Animal Care and Use Committee of the University of Missouri and the Harry S. Truman Memorial Veterans' Hospital Subcommittee for Animal Studies. Six-to eight-week old CF-1 mice were obtained from Charles River Laboratories and housed 1 week prior to the studies. An aliquot of 64 Cu-radiolabeled complex (60 μCi) was prepared as described above and intravenously injected via the tail vein in phosphate-buffered saline (100 μL). At 1, 4 and 24 h post-injection, mice were sacrificed and blood, liver, kidney, muscle and bone were collected, weighed and counted in a gamma counter. The radioactivity from each tissue/organ was decaycorrected by a known aliquot of the injected dose, and the percent-injected dose per gram of tissue (% ID/g) was calculated. Values are presented as mean ± SD for each group of 3 mice.
Results and discussion
The new chelates 3p-C-NE3TA, 3p-C-NOTA, and 3p-C-DE4TA were evaluated for complexation with 64 Cu. Among the known bifunctional chelators of 64 Cu, C-DOTA and C-NOTA were selected for the present study on comparative evaluation for radiolabeling with 64 Cu at room temperature. C-NOTA rapidly forms a stable complex with 64 Cu and possesses superior radiolabeling kinetics and complex stability with 64 Cu than C-DOTA [14, 15] . C-NOTA analogs have been extensively explored for development of 64 Cu-based radiopharmaceuticals [21] [22] [23] . Radiolabeling efficiency of the chelates in binding 64 Cu was measured at room temperature in duplicate using TLC and HPLC (Table 1) . The new chelates 3p-C-NE3TA, 3p-C-NOTA, and 3p-C-DE4TA instantly bound to 64 Cu at room temperature and pH 5.5, and radiolabeling was almost complete at the beginning of the measurement (>99 % radiolabeling efficiency, 3 μCi/ μg specific activity, 1 min, RT). As expected, C-NOTA was extremely rapid in binding 64 Cu, while C-DOTA displayed slower radiolabeling kinetics when compared to all other chelates studied (Table 1) . 3p-C-NE3TA, 3p-C-NOTA, and C-NOTA completely bound to Cu-64 at 30 min as evidenced by both TLC and HPLC analysis. However, radiolabeling of C-DOTA with 64 Cu was incomplete at the 30 min time point. The noted difference in Cu-64 radiolabeling efficiency of C-DOTA measured by TLC (95.4 %) and HPLC (88.6 %) seems to be related to formation of less stable 64 Cu-C-DOTA complexes that can be dissociated during TLC and HPLC analysis.
The 64 Cu-radiolabeled chelates were further evaluated for complex stability in human serum and excess EDTA solution. Copper-64 complexes of 3p-C-NOTA, 3p-C-NE3TA, 3p-C-DE4TA, and C-NOTA were readily prepared by reaction of each chelator with 64 Cu for 1 h at room temperature (pH 5.5, 100 % radiolabeling efficiency, TLC). However, complete radiolabeling of C-DOTA with 64 Cu required significantly longer time (5 h) at room temperature. Therefore, 64 Cu-C-DOTA for the in vitro complex 
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stability studies was prepared from reaction of C-DOTA with 64 Cu for 1 h at 90 °C. Human serum stability studies of 64 Cu-radiolabeled chelates were performed to determine if the complexes remained stable without loss of 64 Cu (37 °C, pH 7). Stability was assessed by measuring the transfer of 64 Cu from the complex to serum proteins over the course of 2 days using TLC and HPLC (Table 2 and Supporting Information). All 64 Cu-radiolabeled chelates remained stable in human serum without 64 Cu being released into the serum over 2 days. Stability of 64 Cu-radiolabeled complexes was further evaluated by challenging the complexes with EDTA at 100-fold molar excess (Table 3 ; Fig. 2 , and Supporting Information). 64 Cu-3p-C-NOTA, 64 Cu-3p-C-NE3TA, and 64 Cu-C-NOTA remained intact in the EDTA solution for 24 h of incubation. The 64 Cu complex of 3p-C-DE4TA with nine donors was not able to hold 64 Cu stably, and a significant amount of 64 Cu was transchelated from the chelate to EDTA over a 24 h incubation time (~50 %). 64 Cu-C-DOTA released >5 % of 64 Cu into the EDTA solution. The in vivo stability of 64 Cu-radiolabeled chelates was evaluated by a biodistribution study using non-tumor bearing CF-1 mice (i.v. injection, n = 3). After injection of 64 Cu-radiolabeled chelates, radioactivity accumulation in harvested organs and blood was measured at 1, 4, and 24 h post-injection ( Fig. 3 and Supporting Information). 64 Cu-3p-C-NE3TA almost completely disappeared from the blood and all organs at 24 h post-injection. The level of the radioactivity accumulated in the blood and in the organs was negligible (<0.2 % ID/g) at 24 h post-injection. The highest uptake of the tracer was observed in the kidney at 1 h post-injection (3.0 % ID/g). The liver (2.5 % ID/g at 1 h) cleared quickly, having less than 0.1 % ID/g remaining at 24 h. No considerable accumulation of the tracer was detected in blood, muscle, and bone during the period of study. 64 Cu-3p-C-NOTA displayed its highest uptake in the liver at 1 h (3.6 % ID/g). However, the tracer rapidly disappeared by 24 h (<0.6 % ID/g). The radioactivity retained in the kidney at 1 h (1.1 % ID/g) cleared out by 24 h. Uptake of radioactivity in the blood and in the other organs was not significant at any time point. Significant radioactivity was released from 64 Cu-3p-C-DE4TA and accumulated in liver and kidney at 1 h (14.3 and 8.2 %, respectively), and the radioactivity was retained in these organs at 24 h (11.1 and 5.7 %, respectively). Blood, bone, and muscle had low levels of the tracer at 24 h (1.5, 1.4, and 0.5 %, respectively). The biodistribution data indicate that 3p-C-NOTA and 3p-C-NE3TA cleared well in vivo, but 64 Cu-3p-C-DE4TA showed substantially higher uptake and retention in the key organs. The instability of the DE4TA complex to EDTA challenge leads us to believe that the chelate dissociated in vivo.
Cu(II) with the prevalent oxidation state of +2 has a small ionic radius (73 pm) for coordination number 6 [24] . The borderline hard and soft Cu(II) is reported to adopt five or six coordination and display high affinity for nitrogen, oxygen, or sulfur donors such as aromatic nitrogens, thiol, amide, aminocarboxylate, and hydroxyl group [7, 25, 26] .
The macrocyclic chelate NOTA with three nitrogens and three oxygen donors forms a stable hexacoordinate complex [25, 27] . Hexa-coordination of Cu(II) with the four nitrogens in the cyclen backbone and two pendant carboxylate oxygens in DOTA produced Cu(II)-DOTA complex with high thermodynamic stability [28] . Copper-64-NOTA was reported to have more favorable complex stability and resistance to transchelation than 64 Cu-DOTA in vivo [15, [21] [22] [23] 29] . It is speculated that the higher kinetic stability of 64 Cu-NOTA relative with 64 Cu-DOTA stems from more favorable size-fit of Cu(II) to the smaller ring TACN.
The complexation radiolabeling and EDTA challenge data confirm that C-DOTA with a larger macrocyclic cavity and higher denticity forms less stable complex with Cu(II) than the TACN-based hexadentate C-NOTA. It should be noted that 64 Cu-C-DOTA complex for the present studies of in vitro stability was prepared from radiolabeling of C-DOTA with 64 Cu at 90 °C for 1 h, while all other chelates were well labeled with 64 Cu at RT. Under the harsh radiolabeling condition, C-DOTA was expected to form thermodynamically more stable complex as reaction of C-DOTA at room temperature could produce less stable intermediate 64 Cu-C-DOTA complexes [30] . However, 64 Cu-C-DOTA was found to be less stable than C-NOTA Cu complex (%) and other TACN-based chelates 3p-C-NOTA and 3p-C-NE3TA when challenged by excess EDTA. In our previous studies, C-DOTA and C-NOTA were comparatively evaluated for in vivo complex stability with 64 Cu, and C-NOTA displayed superior in vivo stability than C-DOTA [15] . Copper-64-labeled C-DOTA was shown to have higher uptake in all tissues at all time points than 64 Cu-C-NOTA (1, 4, and 24 h post-injection, n = 4, female SCID mice). Particularly, significant radioactivity was retained in the liver for 64 Cu-C-DOTA (78 % at 24 h when compared to 1 h), while 64 Cu-C-NOTA displayed lower uptake in the liver at all time points (3 % retention at 24 h when compared to 1 h) [15] .
C-NOTA is built on a small macrocyclic cavity which is expected to be less dynamic in binding a metal than acyclic chelators [20, 31] . 3p-C-NE3TA contains the same TACN backbone as NOTA [19] . By virtue of the acyclic bidentate arm, 3p-C-NE3TA was expected to form a complex with Cu(II) more rapidly. However, the predicted dynamic binding of 3p-C-NE3TA with Cu(II) using seven donors could form a less stable complex than C-NOTA. The in vitro and in vivo data indicate that 3p-C-NE3TA was extremely rapid in binding Cu(II) and formed a stable complex with Cu(II), and 64 Cu-3p-C-NE3TA was well tolerated in the EDTA challenge and produced an excellent biodistribution profile in mice. 64 Cu-3p-C-NE3TA displayed rapid clearance from Cu-radiolabeled bifunctional chelates in non-tumor bearing CF-1 mice
